Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

25 Apr 2017 Evaluate

Alembic Pharmaceuticals has informed about press release titled ‘Alembic Pharmaceuticals receives USFDA Final Approvals for Olmesartan Medoxomil Tablets and Olmesartan Medoxomil with Hydrochlorothiazide Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..